Change language
Hippocampus Bioinformatic Vision Quality Improvement Program
(Furthermore, the term Program shall refer to this title)
1. Program Initiator: Hippocampus Institute Charity Foundation Budapest
Headquarters: 1092 Budapest, Raday u. 8
Contacts:
Telephone: +36-1 -299 0200
Fax: +36-1-299 0201
E-mail: info@hippocampusinstitute.net
Websit www.hippocampusinstitute.net
Program Director: Dr. Anna Pfeifenroth
Telephone: +36-70 -946 6769
E-mail: aniko@fitoreflex.hu
Ophthalmology Director of the Program: Dr. Eniko Hajdu Ophthalmologist
Telephone:+36-70-9673350
Email: hajdu.eniko@slk.hu
Director of Communications: Zsolt Orosz
Telephone: +36-70-9763350
Email: orosz.zsolt@slk.hu
2. Program Mission Statement
a. Clinical data collection inspired by the clinical observations of the last twenty years and eighty five years of bioinformational research in visual health. Although this resulted in a large amount of data and positive results, this data was never been systematically analyzed. This Program aims to collect and analyse the following aspects of research in order to better understand the affects of bioinformational treatments on visual well being.
i. Monitoring the changes in visual perception and the dynamics of these changes.
ii. Tracking the correlation between visual perception and lifestyle changes.
iii. Measuring the correlation between metabolic, visual perception, and lifestyle changes.
iv. Data collection is intended to be used as a starting point for the design of subsequent clinical research projects.
b. Through this program we aim to introduce the holistic paragigm and its prevention related application possibilities. The program then demonstrates this through a method which is easy for everyone and which will produce dramatic and lasting results.
c. The Program seeks to encourage all persons, patients and practitioners alike, to take control of their health and well being for now and for their future; that they might be prepaired for the onset of aging and prevent changes to quality of life.
d. Edcuation will be provided to all inquiring minds, be they participants, their families, and the community at large, that we might create a broader understanding of bioinformatics as a whole. The Program shall dispell misunderstandings and further the knowledge of all who attend; clarifying the bioinformatic applications examined over the last two decades.
3. Program Methods and Execution
a. Methods applied in the Program:
i. Electromagnetic Biocommunication, a.k.a. Bioresonance Therapy
1. Resonance based interaction between Extremely-Low-Intensity electromagnetic signals and the treated organism in order to synchronize metabolic processes.
2. Trigger Therapy targets biocybernetic regulation of the organism; without creating action potential in the nervous system, or direct thermal effect in the tissues.
a. Every kind of influence occurs on the bioinformatic level.
b. From there, through the proper self regulatory system of the organism, the metabolic processes may be influenced.
ii. Lifestyle Consultation
1. The Personal Data sheet and Weekly Report allow us to ask the important questions to stimulate self reflection and thus provide motivation for change.
2. The educational aspect of the Program provides expertise and knowledge crucial to the Therapist when implementing these changes.
b. Program Equipment:
i. Lenyo Lux
1. A signal genorator which has been specifically tuned to the bioinformatic channels within the organism
2. The Program utilizes the Lux program #111, “Eye Short,” which directly affects the eye, the circulation of the eye and those metabolic processes which affect the eye, all connected by the web of electromagnetic biocommunication (Biological windows).
3. The Lenyo Lux consists of the signal generator, the full body applicator, and the local applicator.
ii. Fractal
1. A signal genorator which has been specifically tuned to the bioinformatic channels within the organism
2. The Program utilizes the Fractal program “Eye,” which directly affects the eye, the circulation of the eye and those metabolic processes which affect the eye, all connected by the web of electromagnetic biocommunication (Biological windows).
3. The Fractal consists of the signal generator, the full body applicator, and the local applicator.
c. Program Duration
i. Full Duration: May 15 2007 to May 15 2009
ii. Data Collection Period: May 15 2007 to December 15 2008
iii. Period of Data publication preparation: Dec 16 2008 to May 14 2009
iv. Participant Therapy Duration: 16 weeks
1. Two cycles administered 5 times per week minimum
2. Participants have twenty weeks in which to complete the sixteen weeks of the Program (5 days of 2 cycles each week)
3. Only those Participants which meet these requirements may be included in final data collection. A minimum of eighty therapies and seventeen tests must have been completed.
a. “One Cycle” is defined at a single run through of either the “Eye Short” on the Lux or the “Eye” on the fractal.
b. Every Treatment consists of two consecutive cycles without pause.
d. Program Execution
i. A contract must be signed between Hippocampus Brt North America and the Therapist administering the Program
1. Said contract entitled “Contract of Co-operation Between Hippocampus and Therapist in the Administration of Vision Quality Improvement Program” and adhered to throughout duration of the Program
2. Contract subject to variation as per the Program Director.
3. Program Director must initiate sponsorship of Therapist administering the Program and sign said contact.
ii. Therapist Required Education
1. Bioinformatic and data gathering eduction provided by the Program Director
2. Vision Acquity Tests and Questionair completion training provided by the Opthalmology Director of the Program
3. Education in administering Wellness Status Checks prior to and following admitance to program and treatments.
iii. Treatment Procedure
1. Conduct Wellness Status Check and exclude those whos status may adversly affect Participant.
2. Participant recieves two full cycles of appropriate program, cumulatively totalling eighty treatments
a. One cycle lasts approximately twelve minutes, thirty seconds (12:30)
b. Two cycles will then total approximately twenty five minutes (25:00)
3. During the treatment, both the local and full body applicators should be in use.
a. Full body applicator must be within two inches (2”) or five centimeters (5cm) of the Participants back
b. Local applicator must be within two inches (2”) or five centimeters (5cm) of the Participants eyes
4. It is recommended that the Participant have access to water immediately before and throughout the duration of said treatment. Ideally, sixteen ounces (16 oz.) of water should be consumed during Treatment.
a. Treatment has been shown to be less efficient in a dehydrated state
b. Organism can better adapt after treatment when in a hydrated state
5. Following Treatment, conduct Wellness Status Check on Participant prior to departure.
iv. Administering Tests
1. Participant must undergo Visual Acuity test at commencement of Therapy period and at the end of each week in which a full Treatment Set (five series of two cycles) has been completed.
2. Each Participant should have completed, in totality, seventeen times two tests:
a. On the day of the final treatment of the Treatment Set, each Participant must undergo a visual acuity test prior to treatment and then a second Visual Acuity test five minutes after the completion of the second cycle (thus times two).
v. Completing the Questionnaire
1. Therapist and potential Participant must read and sign “Therapist/Participant Agreement” document
2. Potential Participant must complete “Personal Data” sheet, after which the Therapist can assess suitability of participant and enroll the individual as a Participant.
3. Participant must complete “Personal Data Weekly Report” at the final day of each Treatment Set
4. Results of the Visual Acuity Test must be recorded in the appropriate section on the second page of the “Personal Data Weekly Report”
5. Within ten days of completion, all questionnaires must be submitted to the Program Director
6. At the completion of the Therapy Period, the Participant will have completed fifteen “Personal Data Weekly Reports” and two “Personal Data” forms, one each at the beginning and end of the Therapy Period.
7. The Therapist administering the Program must send all Reports, questionnaires and notes to the Program Director within fifteen days of terminating a given Participants Therapy Period.
vi. Certification
1. After Termination of Therapy Period, the Participant shall receive a Program completion certificate from the Program Director, signed in the name of the foundation
2. After Termination of Therapy Period, the Therapist shall receive a Program completion certificate from the Program Director, signed in the name of the foundation
3. Participant Certificate is valid for $300 USD rebate on the purchase of any Hippocampus Unit within six months of Program completion
4. Hippocampus/Therapist Agreement contract shall define the Hippocampus rebate value of the Therapist Certificate
4. Program Sponsors
a. Hippocampus-BRT Ltd.
i. Contact:
1. Zsuzsa Trombitás – Administrative Assitant, Principal Program Contact
2. Alessandro Vizzari – Web Master and Graphic Design Artist
b. Eni-Med Ltd.
i. Contact:
1. Diána Gáspár – Head administrator, Principal Program Contact
c. Hippocampus-BRT North America Ltd.
i. Contact:
Dr.Arturo O'Birne
e-mail: arturo@BioMD.com
Mobil Ph:+34-659402357
Dr. Morris Zubkevych
e-mail: mzubkewych@bellnet.ca
Mobil Ph:: +1-416-9382564
Dr. T.K.Chou
e-mail: tkc0412@anma.com.tw
Mobil Ph: +886-0933848356,
office phone: +886-223935307
(Furthermore, the term Program shall refer to this title)
1. Program Initiator: Hippocampus Institute Charity Foundation Budapest
Headquarters: 1092 Budapest, Raday u. 8
Contacts:
Telephone: +36-1 -299 0200
Fax: +36-1-299 0201
E-mail: info@hippocampusinstitute.net
Websit www.hippocampusinstitute.net
Program Director: Dr. Anna Pfeifenroth
Telephone: +36-70 -946 6769
E-mail: aniko@fitoreflex.hu
Ophthalmology Director of the Program: Dr. Eniko Hajdu Ophthalmologist
Telephone:+36-70-9673350
Email: hajdu.eniko@slk.hu
Director of Communications: Zsolt Orosz
Telephone: +36-70-9763350
Email: orosz.zsolt@slk.hu
2. Program Mission Statement
a. Clinical data collection inspired by the clinical observations of the last twenty years and eighty five years of bioinformational research in visual health. Although this resulted in a large amount of data and positive results, this data was never been systematically analyzed. This Program aims to collect and analyse the following aspects of research in order to better understand the affects of bioinformational treatments on visual well being.
i. Monitoring the changes in visual perception and the dynamics of these changes.
ii. Tracking the correlation between visual perception and lifestyle changes.
iii. Measuring the correlation between metabolic, visual perception, and lifestyle changes.
iv. Data collection is intended to be used as a starting point for the design of subsequent clinical research projects.
b. Through this program we aim to introduce the holistic paragigm and its prevention related application possibilities. The program then demonstrates this through a method which is easy for everyone and which will produce dramatic and lasting results.
c. The Program seeks to encourage all persons, patients and practitioners alike, to take control of their health and well being for now and for their future; that they might be prepaired for the onset of aging and prevent changes to quality of life.
d. Edcuation will be provided to all inquiring minds, be they participants, their families, and the community at large, that we might create a broader understanding of bioinformatics as a whole. The Program shall dispell misunderstandings and further the knowledge of all who attend; clarifying the bioinformatic applications examined over the last two decades.
3. Program Methods and Execution
a. Methods applied in the Program:
i. Electromagnetic Biocommunication, a.k.a. Bioresonance Therapy
1. Resonance based interaction between Extremely-Low-Intensity electromagnetic signals and the treated organism in order to synchronize metabolic processes.
2. Trigger Therapy targets biocybernetic regulation of the organism; without creating action potential in the nervous system, or direct thermal effect in the tissues.
a. Every kind of influence occurs on the bioinformatic level.
b. From there, through the proper self regulatory system of the organism, the metabolic processes may be influenced.
ii. Lifestyle Consultation
1. The Personal Data sheet and Weekly Report allow us to ask the important questions to stimulate self reflection and thus provide motivation for change.
2. The educational aspect of the Program provides expertise and knowledge crucial to the Therapist when implementing these changes.
b. Program Equipment:
i. Lenyo Lux
1. A signal genorator which has been specifically tuned to the bioinformatic channels within the organism
2. The Program utilizes the Lux program #111, “Eye Short,” which directly affects the eye, the circulation of the eye and those metabolic processes which affect the eye, all connected by the web of electromagnetic biocommunication (Biological windows).
3. The Lenyo Lux consists of the signal generator, the full body applicator, and the local applicator.
ii. Fractal
1. A signal genorator which has been specifically tuned to the bioinformatic channels within the organism
2. The Program utilizes the Fractal program “Eye,” which directly affects the eye, the circulation of the eye and those metabolic processes which affect the eye, all connected by the web of electromagnetic biocommunication (Biological windows).
3. The Fractal consists of the signal generator, the full body applicator, and the local applicator.
c. Program Duration
i. Full Duration: May 15 2007 to May 15 2009
ii. Data Collection Period: May 15 2007 to December 15 2008
iii. Period of Data publication preparation: Dec 16 2008 to May 14 2009
iv. Participant Therapy Duration: 16 weeks
1. Two cycles administered 5 times per week minimum
2. Participants have twenty weeks in which to complete the sixteen weeks of the Program (5 days of 2 cycles each week)
3. Only those Participants which meet these requirements may be included in final data collection. A minimum of eighty therapies and seventeen tests must have been completed.
a. “One Cycle” is defined at a single run through of either the “Eye Short” on the Lux or the “Eye” on the fractal.
b. Every Treatment consists of two consecutive cycles without pause.
d. Program Execution
i. A contract must be signed between Hippocampus Brt North America and the Therapist administering the Program
1. Said contract entitled “Contract of Co-operation Between Hippocampus and Therapist in the Administration of Vision Quality Improvement Program” and adhered to throughout duration of the Program
2. Contract subject to variation as per the Program Director.
3. Program Director must initiate sponsorship of Therapist administering the Program and sign said contact.
ii. Therapist Required Education
1. Bioinformatic and data gathering eduction provided by the Program Director
2. Vision Acquity Tests and Questionair completion training provided by the Opthalmology Director of the Program
3. Education in administering Wellness Status Checks prior to and following admitance to program and treatments.
iii. Treatment Procedure
1. Conduct Wellness Status Check and exclude those whos status may adversly affect Participant.
2. Participant recieves two full cycles of appropriate program, cumulatively totalling eighty treatments
a. One cycle lasts approximately twelve minutes, thirty seconds (12:30)
b. Two cycles will then total approximately twenty five minutes (25:00)
3. During the treatment, both the local and full body applicators should be in use.
a. Full body applicator must be within two inches (2”) or five centimeters (5cm) of the Participants back
b. Local applicator must be within two inches (2”) or five centimeters (5cm) of the Participants eyes
4. It is recommended that the Participant have access to water immediately before and throughout the duration of said treatment. Ideally, sixteen ounces (16 oz.) of water should be consumed during Treatment.
a. Treatment has been shown to be less efficient in a dehydrated state
b. Organism can better adapt after treatment when in a hydrated state
5. Following Treatment, conduct Wellness Status Check on Participant prior to departure.
iv. Administering Tests
1. Participant must undergo Visual Acuity test at commencement of Therapy period and at the end of each week in which a full Treatment Set (five series of two cycles) has been completed.
2. Each Participant should have completed, in totality, seventeen times two tests:
a. On the day of the final treatment of the Treatment Set, each Participant must undergo a visual acuity test prior to treatment and then a second Visual Acuity test five minutes after the completion of the second cycle (thus times two).
v. Completing the Questionnaire
1. Therapist and potential Participant must read and sign “Therapist/Participant Agreement” document
2. Potential Participant must complete “Personal Data” sheet, after which the Therapist can assess suitability of participant and enroll the individual as a Participant.
3. Participant must complete “Personal Data Weekly Report” at the final day of each Treatment Set
4. Results of the Visual Acuity Test must be recorded in the appropriate section on the second page of the “Personal Data Weekly Report”
5. Within ten days of completion, all questionnaires must be submitted to the Program Director
6. At the completion of the Therapy Period, the Participant will have completed fifteen “Personal Data Weekly Reports” and two “Personal Data” forms, one each at the beginning and end of the Therapy Period.
7. The Therapist administering the Program must send all Reports, questionnaires and notes to the Program Director within fifteen days of terminating a given Participants Therapy Period.
vi. Certification
1. After Termination of Therapy Period, the Participant shall receive a Program completion certificate from the Program Director, signed in the name of the foundation
2. After Termination of Therapy Period, the Therapist shall receive a Program completion certificate from the Program Director, signed in the name of the foundation
3. Participant Certificate is valid for $300 USD rebate on the purchase of any Hippocampus Unit within six months of Program completion
4. Hippocampus/Therapist Agreement contract shall define the Hippocampus rebate value of the Therapist Certificate
4. Program Sponsors
a. Hippocampus-BRT Ltd.
i. Contact:
1. Zsuzsa Trombitás – Administrative Assitant, Principal Program Contact
2. Alessandro Vizzari – Web Master and Graphic Design Artist
b. Eni-Med Ltd.
i. Contact:
1. Diána Gáspár – Head administrator, Principal Program Contact
c. Hippocampus-BRT North America Ltd.
i. Contact:
Dr.Arturo O'Birne
e-mail: arturo@BioMD.com
Mobil Ph:+34-659402357
Dr. Morris Zubkevych
e-mail: mzubkewych@bellnet.ca
Mobil Ph:: +1-416-9382564
Dr. T.K.Chou
e-mail: tkc0412@anma.com.tw
Mobil Ph: +886-0933848356,
office phone: +886-223935307